access & pricing of orphan drugs
Published 1 year ago • 22 plays • Length 6:13Download video MP4
Download video MP3
Similar videos
-
2:34
orphan drug development, pricing, and access
-
7:07
eu market access 2021- what’s in store for orphan drugs and atmps?
-
7:07
eu market access 2021: what’s in store for orphan drugs and atmps?
-
3:18
what are orphan medicines? - video explainer
-
5:53
the orphan drug act and rare disease drug pricing
-
26:31
origins: orphan genes puzzle
-
6:17
turing ceo martin shkreli talks 5,000% drug price hike (full interview) | cnbc
-
6:41
orphan drugs: an introduction
-
1:14
issue update: closing loopholes for orphan drugs act
-
0:40
how can specialty pharmacies reduce the cost of orphan drugs?
-
1:15:13
orphan medicine market access in europe: growing challenges ahead | market access webinar
-
1:04:54
the rare disease drug dilemma: great value, high price, limited access?
-
3:01
the annual cost of orphan drugs
-
9:12
orphan drug development | episode 01- what is orphan drug? | rare disease | drug regulatory affairs
-
1:00:37
rare disease market access webinar: challenges facing orphan medicines entering europe
-
20:38
early access to orphan drugs – the rationale, challenges and options available
-
0:38
orphan drugs: cost vs benefits
-
43:23
fda orphan drugs program and financial incentives for cder medical products- june 10, 2019
-
57:16
seminar on drug pricing: aidan hollis, 6 august 2015
-
25:26
5th eurordis survey on access to orphan drugs in europe
-
46:26
ft pharma 2021 - pricing and market access trends session
-
1:15:09
orphan medicines: how to sustain innovation in an area of high unmet need?